09 July 2012

Systemic Lupus Erythematosus (SLE)



Systemic Lupus Erythematosus
Steve Beesley
http://ruby.fgcu.edu/

Systemic Lupus Erythematosus
http://isites.harvard.edu/

Systemic Lupus Erythematosus (SLE)
Heidi Roppelt, MD
https://cbase.som.sunysb.edu/

Systemic Lupus Erythematosus
Cassidy Summers, Tricia Molett, Summer Lashley, Kelly Winship
http://mailer.fsu.edu

Systemic Lupus Erythematosus (SLE)
http://www.austincc.edu/

Lupus
http://sest.vsu.edu/

SLE: Fighting Self Sabotage
Susan Manzi, MD, MPH
http://www.pitt.edu

Autoimmune diseases
Henry O. Ogedegbe, PhD., C(ASCP)SC
http://ruby.fgcu.edu

What’s New in Lupus
Jennifer H. Anolik, MD, PhD
http://www.urmc.rochester.edu

Emergency Issues in Pediatric Rheumatology
Elivette Zambrana-Flores
http://www.pediatrics.emory.edu

Neuropsychiatric Lupus
SEULI BOSE BRILL, MD
https://medicine.med.unc.edu/


Latest 200 full text articles free access
1.    Alunno A, Bartoloni E, Bistoni O, Nocentini G, Ronchetti S, Caterbi S, Valentini V, Riccardi C, Gerli R. Balance between Regulatory T and Th17 Cells in  Systemic Lupus Erythematosus. The Old and the New. Clin Dev Immunol. 2012;2012:823085. Epub 2012 Jun 14.
2.    Alegretti AP, Schneider L, Piccoli AK, Monticielo OA, Lora PS, Brenol JC, Xavier RM. Diminished expression of complement regulatory proteins on peripheral  blood cells from systemic lupus erythematosus patients. Clin Dev Immunol. 2012;2012:725684. Epub 2012 Jun 12.
3.    Yang Y, Ye Y, Liang L, Wu T, Zhan Z, Yang X, Xu H. Systemic-lupus-erythematosus-related acute pancreatitis. a cohort from South china. Clin Dev Immunol. 2012;2012:568564. Epub 2012 Jun 19.
4.    Chuang YP, Wang CH, Wang NC, Chang DM, Sytwu HK. Modulatory function of invariant natural killer T cells in systemic lupus erythematosus. Clin Dev Immunol. 2012;2012:478429. Epub 2012 Jun 13.
5.    Zanuto AC, Bueno T, Delfino VD, Mocelin AJ. Nephrocalcinosis in a patient with Sjögren's syndrome/systemic lupus erythematosus. Rev Assoc Med Bras. 2012 Jun;58(3):279-80.
6.    Butbul Aviel Y, Mandel H, Avitan 8211 Hersh E, Reuven B, Orly EA, Anthony L, Riva B. Prolidase deficiency associated with systemic lupus erythematosus (SLE).  single site experience and literature review. Pediatr Rheumatol Online J. 2012 Jun 22;10(1):18. [Epub ahead of print]
7.    Wu T, Xie C, Han J, Ye Y, Weiel J, Li Q, Blanco I, Ahn C, Olsen N, Putterman C, Saxena R, Mohan C. Metabolic disturbances associated with systemic lupus erythematosus. PLoS One. 2012;7(6):e37210. Epub 2012 Jun 19.
8.    Tunccan OG, Tufan A, Telli G, Akyürek N, Pamukçuoğlu M, Yılmaz G, Hızel K. Visceral leishmaniasis mimicking autoimmune hepatitis, primary biliary cirrhosis, and systemic lupus erythematosus overlap. Korean J Parasitol. 2012 Jun;50(2):133-6. Epub 2012 May 24.
9.    Habibi S, Saleem MA, Ramanan AV. Juvenile Systemic Lupus Erythematosus Review  of Clinical Features and Management. Indian Pediatr. 2011 Nov 8;48(11):879-887.
10.    Yoshimi R, Ishigatsubo Y, Ozato K. Autoantigen TRIM21/Ro52 as a Possible Target for Treatment of Systemic Lupus Erythematosus. Int J Rheumatol. 2012;2012:718237. Epub 2012 Jun 4.
11.    Matsumura M, Suzuki Y, Yamagishi M, Kawano M. Prominent ridged nail deformity in systemic lupus erythematosus. Intern Med. 2012;51(10):1283-4. Epub 2012 May 15.
12.    Beppu M, Kawamoto M, Nukuzuma S, Kohara N. Mefloquine improved progressive multifocal leukoencephalopathy in a patient with systemic lupus erythematosus. Intern Med. 2012;51(10):1245-7. Epub 2012 May 15.
13.    Oshima T, Okugawa T, Hori K, Kim Y, Tanaka J, Watari J, Miwa H. Successful endoscopic submucosal dissection of gastric carcinoid in a patient with autoimmune gastritis and systemic lupus erythematosus. Intern Med. 2012;51(10):1211-3. Epub 2012 May 15.
14.    Shao Y, Zhang J, Chen Y, Wu Q, Guan M, Yu B, Wan J, Zhang W. The Association  of IL-12b Polymorphisms with Systemic Lupus Erythematosus in Chinese Han Population. Int J Rheumatol. 2012;2012:724872. Epub 2012 May 16.
15.    Nayak RB, Bhogale GS, Patil NM, Chate SS. Psychosis in patients with systemic lupus erythematosus. Indian J Psychol Med. 2012 Jan;34(1):90-3.
16.    Radhakrishnan R, Menon J, Kanigere M, Ashok M, Shobha V, Galgali RB. Domains  and determinants of quality of life in schizophrenia and systemic lupus erythematosus. Indian J Psychol Med. 2012 Jan;34(1):49-55.
17.    Zhao M, Liang G, Luo S, Lu Q. [Effect of total glucosides of peony on expression and DNA methylation status of ITGAL gene in CD4(+) T cells of systemic lupus erythematosus]. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2012 May;37(5):463-8.  Chinese.
18.    Connolly JJ, Hakonarson H. Role of Cytokines in Systemic Lupus Erythematosus. Recent Progress from GWAS and Sequencing. J Biomed Biotechnol. 2012;2012:798924.  Epub 2012 May 10.
19.    Klack K, Bonfa E, Borba Neto EF. Diet and nutritional aspects in systemic lupus erythematosus. Rev Bras Reumatol. 2012 Jun;52(3):395-408. English, Portuguese.
20.    Zou X, Zhuang Y, Dong FT, Zhang F, Chen YX. Sequential bilateral central retinal artery occlusion as the primary manifestation of systemic lupus erythematosus. Chin Med J (Engl). 2012 Apr;125(8):1517-9.
21.    Xia LX, Ding X, Li X, Zhang FC, Tang FL, Zhang X, Ba DN, He W. Abnormal expression of CD43 in patients with systemic lupus erythematosus and its clinical significance. Chin Med J (Engl). 2012 Apr;125(7):1266-71.
22.    Somers EC, Zhao W, Lewis EE, Wang L, Wing JJ, Sundaram B, Kazerooni EA, McCune WJ, Kaplan MJ. Type I interferons are associated with subclinical markers  of cardiovascular disease in a cohort of systemic lupus erythematosus patients. PLoS One. 2012;7(5):e37000. Epub 2012 May 14.
23.    Hernando Rubio I, Belzunegui Otano J, Máiz Alonso O, Alvarez Rodríguez B. Transverse myelitis and bilateral optic neuritis in a patient with systemic lupus erythematosus. Reumatol Clin. 2012 May 15. [Epub ahead of print] English, Spanish.
24.    Lamore R 3rd, Parmar S, Patel K, Hilas O. Belimumab (benlysta). a breakthrough therapy for systemic lupus erythematosus. P T. 2012 Apr;37(4):212-26.
25.    Redondo-Pachón MD, Enríquez R, Sirvent AE, Andrada E, Millán I, Amorós F. Minimal-change nephropathy in systemic lupus erythematosus. Nefrologia. 2012 May  14;32(3):412-3. doi. 10.3265/Nefrologia.pre2012.Feb.11372. English, Spanish.
26.    Lian LH, Lau TP, Ching AS, Chua KH. Angiotensin-converting enzyme gene I/D dimorphism does not play a major role in the susceptibility of Malaysian systemic lupus erythematosus patients. Genet Mol Res. 2012 Apr 10;11(2):863-71.
27.    Martins PR, Skare T, Ferrari TA, Silva AP, Alessio BF. Comparative analysis of the quality of life of patients with discoid lupus erythematosus and systemic  lupus erythematosus with skin injuries. An Bras Dermatol. 2012 Apr;87(2):326-8.
28.    Pahwa P, Khaitan BK, Rao A, Kriplani A, Mahey R, Subbarao KC. Aggressive angiomyxoma of the vulva in a patient with systemic lupus erythematosus. Indian J Dermatol Venereol Leprol. 2012 May-Jun;78(3):361-4.
29.    Maheshwari A, Pandey M, Rath B, Chandra J, Singh S, Sharma S. Clinical and laboratory observation systemic lupus erythematosus and acute lymphocytic leukemia. An unusual case. Indian J Med Paediatr Oncol. 2011 Jul;32(3):154-6.
30.    Chiang LL, Lin YT, Chan HY, Chiang BL. Differential manifestations of prepubescent, pubescent and postpubescent pediatric patients with systemic lupus  erythematosus. A retrospective study of 96 Chinese children and adolescents. Pediatr Rheumatol Online J. 2012 May 2;10(1):12. [Epub ahead of print]
31.    Manzi S, Sánchez-Guerrero J, Merrill JT, Furie R, Gladman D, Navarra SV, Ginzler EM, D'Cruz DP, Doria A, Cooper S, Zhong ZJ, Hough D, Freimuth W, Petri MA; on behalf of the BLISS-52 and BLISS-76 Study Groups. Effects of belimumab, a  B lymphocyte stimulator-specific inhibitor, on disease activity across multiple organ domains in patients with systemic lupus erythematosus. combined results from two phase III trials. Ann Rheum Dis. 2012 May 11. [Epub ahead of print]
32.    Goel R, Danda D, Mathew J, Chacko A. Pancreatitis in systemic lupus erythematosus - case series from a tertiary care center in South India. Open Rheumatol J. 2012;6:21-3. Epub 2012 Apr 11.
33.    Kasar PA, Mathew M, Abraham G, Kumar RS. Occult systemic lupus erythematosus  with active lupus nephritis presenting as Libman-Sacks endocarditis. Ann Pediatr  Cardiol. 2012 Jan;5(1):85-8.
34.    Nowicka A, Piątkowska A, Biegalski W, Dankowski R, Michalski M, Szymanowska K, Szyszka A, Jemielity M, Seniuk W, Sosnowski P. [Severe mitral regurgitation as the first symptom of systemic lupus erythematosus in a young women required mitral valve replacement]. Kardiol Pol. 2012;70(4):421-3. Polish.
35.    Cerovec M, Anić B, Padjen I, Cikes N. Prevalence of the American College of Rheumatology classification criteria in a group of 162 systemic lupus erythematosus patients from Croatia. Croat Med J. 2012 Apr;53(2):149-54.
36.    Ye H, Chen S, An Y. [Maternal and fetal outcomes in systemic lupus erythematosus. analysis of 41 patients]. Beijing Da Xue Xue Bao. 2012 Apr 18;44(2):233-5. Chinese.
37.    Wang YF, Pang CY, Ma XF, An Y, Feng XY. [Role of glucocorticoid receptor in the pathogenesis of systemic lupus erythematosus]. Beijing Da Xue Xue Bao. 2012 Apr 18;44(2):229-32. Chinese.
38.    Yang T, Huang CB, Lai B, Zhao LK, Chen YJ, Zhao YT, Zhang CM, Zeng XF. [Role  of anti c-mpl antibody in systemic lupus erythematosus with thrombocytopenia]. Beijing Da Xue Xue Bao. 2012 Apr 18;44(2):221-4. Chinese.
39.    Pan Y, Li XP, Sun JF, Wang L, Chen Z, Li XM, Tao JH, Qian L, Zhang H. [Effects of glucocorticoids on the expression of GTIR and apoptosis of the CD4(+)CD25(+)CD127(dim/-) T cells in patients with systemic lupus erythematosus]. Beijing Da Xue Xue Bao. 2012 Apr 18;44(2):215-20. Chinese.
40.    Pan X, Yuan X, Zheng Y, Wang W, Shan J, Lin F, Jiang G, Yang YH, Wang D, Xu D, Shen L. Increased CD45RA+ FoxP3(low) regulatory T cells with impaired suppressive function in patients with systemic lupus erythematosus. PLoS One. 2012;7(4):e34662. Epub 2012 Apr 10.
41.    Poole BD, Niewold TB, Tsokos GC. Cytokines in systemic lupus erythematosus 2011. J Biomed Biotechnol. 2012;2012:427824. Epub 2011 Dec 29.
42.    Postal M, Costallat LT, Appenzeller S. Biological therapy in systemic lupus erythematosus. Int J Rheumatol. 2012;2012:578641. Epub 2012 Jan 30.
43.    Yang CC, Hsieh SC, Li KJ, Wu CH, Lu MC, Tsai CY, Yu CL. Urinary neutrophil gelatinase-associated lipocalin is a potential biomarker for renal damage in patients with systemic lupus erythematosus. J Biomed Biotechnol. 2012;2012:759313. Epub 2012 Feb 15.
44.    Dhala A. Pulmonary arterial hypertension in systemic lupus erythematosus. current status and future direction. Clin Dev Immunol. 2012;2012:854941. Epub 2012 Mar 22.
45.    Martínez-Martínez MU, Abud-Mendoza C. Serum cystatin C as a marker of renal function in patients with systemic lupus erythematosus. Reumatol Clin. 2012 May-Jun;8(3):158-9. Epub 2012 Apr 5.
46.    Patel T, Fenves A, Colbert G. The de novo diagnosis of systemic lupus erythematosus and lupus nephritis during pregnancy. Proc (Bayl Univ Med Cent). 2012 Apr;25(2):129-31.
47.    Rodríguez-Hurtado FJ, Sáez-Moreno JA, Rodríguez-Ferrer JM. Maculopathy in patient with systemic lupus erythematosus treated with hydroxychloroquine. Reumatol Clin. 2012 Apr 3. [Epub ahead of print] English, Spanish.
48.    Valizadeh N, Vahed SN. Coexistence of pituitary macroadenoma with systemic lupus erythematosus and antiphospholipid syndrome. Indian J Endocrinol Metab. 2012 Mar;16(2):321-2.
49.    Conti F, Alessandri C, Perricone C, Scrivo R, Rezai S, Ceccarelli F, Spinelli FR, Ortona E, Marianetti M, Mina C, Valesini G. Neurocognitive dysfunction in systemic lupus erythematosus. association with antiphospholipid antibodies, disease activity and chronic damage. PLoS One. 2012;7(3):e33824. Epub 2012 Mar 26.
50.    Barbosa Vde S, Rêgo J, Antônio da Silva N. Possible role of adipokines in systemic lupus erythematosus and rheumatoid arthritis. Rev Bras Reumatol. 2012 Mar-Apr;52(2):278-87. English, Portuguese.
51.    de Melo LF, Da-Silva SL. Neuropsychological assessment of cognitive disorders in patients with fibromyalgia, rheumatoid arthritis, and systemic lupus erythematosus. Rev Bras Reumatol. 2012 Mar-Apr;52(2):181-8. English, Portuguese.
52.    Gulhane S, Gangane N. Detection of lupus erythematosus cells in pleural effusion. An unusual presentation of systemic lupus erythematosus. J Cytol. 2012  Jan;29(1):77-9.
53.    Albishri JA. Chorea as a first manifestation in young patients with systemic  lupus erythematosus who was initially diagnosed with rheumatic Fever. Clin Med Insights Case Rep. 2012;5:19-21. Epub 2012 Feb 29.
54.    Kim YS, Park BS, Baek W, Kim SH. Massive vasculitic cerebellar infarction in  patient with systemic lupus erythematosus. Neurol India. 2012 Jan-Feb;60(1):106-8.
55.    Belibou C, Ancuţa C, Ancuţa E, Filoş C, Chirieac R. Carotid intima-media thickness and plaque as surrogate biomarkers of atherosclerosis among consecutive women with systemic lupus erythematosus. Rom J Morphol Embryol. 2012;53(1):29-34.
56.    Ou JN, Wiedeman AE, Stevens AM. TNF-α and TGF-β Counter-Regulate PD-L1 Expression on Monocytes in Systemic Lupus Erythematosus. Sci Rep. 2012;2:295. Epub 2012 Mar 2.
57.    Popescu A, Kao AH. Neuropsychiatric systemic lupus erythematosus. Curr Neuropharmacol. 2011 Sep;9(3):449-57.
58.    Koarada S, Tashiro S, Suematsu R, Inoue H, Ohta A, Tada Y. [BCMA and autoantibody-producing RP105 B cells; possible new targets of B cell therapy in systemic lupus erythematosus]. Nihon Rinsho Meneki Gakkai Kaishi. 2012;35(1):38-45. Review. Japanese.
59.    Orme J, Mohan C. Macrophage subpopulations in systemic lupus erythematosus. Discov Med. 2012 Feb;13(69):151-8. Review.
60.    Kojuri J, Nazarinia MA, Ghahartars M, Mahmoody Y, Rezaian Gr, Liaghat L. QT dispersion in patients with systemic lupus erythematosus. the impact of disease activity. BMC Cardiovasc Disord. 2012 Feb 27;12:11.
61.    Ching KH, Burbelo PD, Tipton C, Wei C, Petri M, Sanz I, Iadarola MJ. Two major autoantibody clusters in systemic lupus erythematosus. PLoS One. 2012;7(2):e32001. Epub 2012 Feb 21.
62.    Abdulla E, Al-Zakwani I, Baddar S, Abdwani R. Extent of subclinical pulmonary involvement in childhood onset systemic lupus erythematosus in the sultanate of oman. Oman Med J. 2012 Jan;27(1):36-9.
63.    Azfar SF, Islam N. Suppression of mycobacterium tuberculosis induced reactive oxygen species and tumor necrosis factor-alpha activity in human monocytes of systemic lupus erythematosus patients by reduced glutathione. Oman Med J. 2012 Jan;27(1):11-9.
64.    Postal M, Sinicato NA, Peliçari KO, Marini R, Lavras Costallat LT, Appenzeller S. Clinical and serological manifestations associated with interferon-α levels in childhood-onset systemic lupus erythematosus. Clinics (Sao Paulo). 2012;67(2):157-62.
65.    Colombo BM, Canevali P, Magnani O, Rossi E, Puppo F, Zocchi MR, Poggi A. Defective expression and function of the leukocyte associated Ig-like receptor 1  in B lymphocytes from systemic lupus erythematosus patients. PLoS One. 2012;7(2):e31903. Epub 2012 Feb 15. Erratum in. PLoS One. 2012;7(6). doi/10.1371/annotation/1ada33bd-76c7-4b66-906f-950b383111e8.
66.    Huard B, Tran NL, Benkhoucha M, Manzin-Lorenzi C, Santiago-Raber ML. Selective APRIL blockade delays systemic lupus erythematosus in mouse. PLoS One.  2012;7(2):e31837. Epub 2012 Feb 15.
67.    Huang CF, Wang WM, Chiang CP. Scaly ear rash as the herald of a young girl with juvenile systemic lupus erythematosus. Ann Dermatol. 2011 Dec;23(Suppl 3):S333-7. Epub 2011 Dec 27.
68.    Jaybhaye AP, Sutay NR, Chate SV, Rathod TN. Juvenile systemic lupus erythematosus. A diagnostic dilemma. J Nat Sci Biol Med. 2011 Jul;2(2):229-31.
69.    van Vollenhoven RF, Petri MA, Cervera R, Roth DA, Ji BN, Kleoudis CS, Zhong ZJ, Freimuth W. Belimumab in the treatment of systemic lupus erythematosus. high  disease activity predictors of response. Ann Rheum Dis. 2012 Apr 5. [Epub ahead of print]
70.    Yu SL, Kuan WP, Wong CK, Li EK, Tam LS. Immunopathological roles of cytokines, chemokines, signaling molecules, and pattern-recognition receptors in  systemic lupus erythematosus. Clin Dev Immunol. 2012;2012:715190. Epub 2012 Jan 23. Review.
71.    Martínez-Martínez MU, Abud-Mendoza C. Economic impact of estimating renal function in patients with systemic lupus erythematosus. Nefrologia. 2012;32(1):122-3. doi. 10.3265/Nefrologia.pre2011.Oct.11097. English, Spanish.
72.    Jung RE, Chavez RS, Flores RA, Qualls C, Sibbitt WL Jr, Roldan CA. White matter correlates of neuropsychological dysfunction in systemic lupus erythematosus. PLoS One. 2012;7(1):e28373. Epub 2012 Jan 26.
73.    Skrętkowicz J, Barańska M, Kaczorowska A, Rychlik-Sych M. Genetic polymorphisms of CYP2D6 oxidation in patients with systemic lupus erythematosus.  Arch Med Sci. 2011 Oct;7(5):864-9. Epub 2011 Nov 8.
74.    Banyś A, Kaźmierski J, Jaszewski R. Psychiatric manifestations in a patient after surgical management of aortic stenosis of systemic lupus erythematosus. Arch Med Sci. 2011 Apr;7(2):342-4. Epub 2011 May 17.
75.    Pott Júnior H, Amate Neto A, Teixeira MA, Provenza JR. Ascites due to lupus peritonitis. a rare form of onset of systemic lupus erythematosus. Rev Bras Reumatol. 2012 Jan-Feb;52(1):116-9. English, Portuguese.
76.    Fragoso TS, Dantas AT, Marques CD, Rocha Junior LF, Melo JH, Costa AJ, Duarte AL. 25-Hydroxyivitamin D3 levels in patients with systemic lupus erythematosus and its association with clinical parameters and laboratory tests. Rev Bras Reumatol. 2012 Jan-Feb;52(1):60-5. English, Portuguese.
77.    Costa MR, Costa IP, Devalle S, Castro AR, Freitas SZ. Prevalence and genetic  diversity of torque teno virus in patients with systemic lupus erythematosus in a reference service in Mato Grosso do Sul. Rev Bras Reumatol. 2012 Jan-Feb;52(1):49-54. English, Portuguese.
78.    Mashhadi MA, Bari Z. Thrombotic thrombocytopenic purpura and deep vein thrombosis as the presenting manifestations of systemic lupus erythematosus. A case report and review of literature. J Res Med Sci. 2011 Aug;16(8):1082-8.
79.    Torabinejad S, Mardani R, Habibagahi Z, Roozbeh J, Khajedehi P, Pakfetrat M,  Banihashemi MA, Banihashemi SJ. Urinary monocyte chemotactic protein-1 and transforming growth factor-β in systemic lupus erythematosus. Indian J Nephrol. 2012 Jan;22(1):5-12.
80.    Kleczynska W, Jakiela B, Plutecka H, Milewski M, Sanak M, Musial J. Imbalance between Th17 and regulatory T-cells in systemic lupus erythematosus. Folia Histochem Cytobiol. 2011;49(4):646-53.
81.    Mathew M, Cherian A. Intracranial hypertension with delayed puberty. a rare presentation of juvenile onset systemic lupus erythematosus. Singapore Med J. 2012 Jan;53(1):e15-7.
82.    Bonakdar ZS, Mohtasham N, Karimifar M. Evaluation of damage index and its association with risk factors in patients with systemic lupus erythematosus. J Res Med Sci. 2011 Mar;16 Suppl 1:S427-32.
83.    Fernando MM, Freudenberg J, Lee A, Morris DL, Boteva L, Rhodes B, Gonzalez-Escribano MF, Lopez-Nevot MA, Navarra SV, Gregersen PK, Martin J; IMAGEN, Vyse TJ. Transancestral mapping of the MHC region in systemic lupus erythematosus identifies new independent and interacting loci at MSH5, HLA-DPB1 and HLA-G. Ann Rheum Dis. 2012 May;71(5):777-84. Epub 2012 Jan 10.
84.    Diez-Morrondo C, Pantoja-Zarza L, Manjón-Haces JA. Kikuchi Fujimoto's disease appearing as systemic lupus erythematosus. Reumatol Clin. 2012 May-Jun;8(3):153-5. Epub 2012 Jan 4.
85.    Okamoto A, Fujio K, Okamura T, Yamamoto K. Regulatory T-cell-associated cytokines in systemic lupus erythematosus. J Biomed Biotechnol. 2011;2011:463412. Epub 2011 Dec 18. Review.
86.    Gonçalves FG, Lamb L, Del Carpio-O'Donovan R. Progressive multifocal leukoencephalopathy restricted to the posterior fossa in a patient with systemic  lupus erythematosus. Braz J Infect Dis. 2011 Dec;15(6):609-12.
87.    Chiu CC, Huang CC, Chan WL, Chung CM, Huang PH, Lin SJ, Chen JW, Leu HB. Increased risk of ischemic stroke in patients with systemic lupus erythematosus.  a nationwide population-based study. Intern Med. 2012;51(1):17-21. Epub 2012 Jan  1.
88.    Tselios K, Tsioka R, Sarantopoulos A, Mouloudi E, Boura P. Influenza A/H1N1 septic shock in a patient with systemic lupus erythematosus. A case report. BMC Infect Dis. 2011 Dec 29;11:358.
89.    Hong YH, Yun DY, Jung YW, Oh MJ, Kim HJ, Lee CK. A case of minimal change disease treated successfully with mycophenolate mofetil in a patient with systemic lupus erythematosus. Korean J Intern Med. 2011 Dec;26(4):470-3. Epub 2011 Nov 28.
90.    Alonso-Perez E, Suarez-Gestal M, Calaza M, Witte T, Papasteriades C, Marchini M, Migliaresi S, Kovacs A, Ordi-Ros J, Bijl M, Santos MJ, Ruzickova S, Pullmann R, Carreira P, Skopouli FN, D'Alfonso S, Sebastiani GD, Suarez A, Blanco FJ, Gomez-Reino JJ, Gonzalez A; European Consortium of SLE DNA Collections. Association of systemic lupus erythematosus clinical features with European population genetic substructure. PLoS One. 2011;6(12):e29033. Epub 2011 Dec 14.
91.    Jeffries MA, Sawalha AH. Epigenetics in systemic lupus erythematosus. leading the way for specific therapeutic agents. Int J Clin Rheumtol. 2011 Aug;6(4):423-439.
92.    Avijgan M, Meidani M, Salesi M, Rezaei F. Hepatic necrosis. a main presentation of systemic lupus erythematosus in a previously healthy woman. Int J Prev Med. 2011 Oct;2(4):286-90.
93.    Ramos PS, Criswell LA, Moser KL, Comeau ME, Williams AH, Pajewski NM, Chung SA, Graham RR, Zidovetzki R, Kelly JA, Kaufman KM, Jacob CO, Vyse TJ, Tsao BP, Kimberly RP, Gaffney PM, Alarcón-Riquelme ME, Harley JB, Langefeld CD; International Consortium on the Genetics of Systemic Erythematosus. A comprehensive analysis of shared loci between systemic lupus erythematosus (SLE)  and sixteen autoimmune diseases reveals limited genetic overlap. PLoS Genet. 2011 Dec;7(12):e1002406. Epub 2011 Dec 8.
94.    Jönsen A, Nilsson SC, Ahlqvist E, Svenungsson E, Gunnarsson I, Eriksson KG, Bengtsson A, Zickert A, Eloranta ML, Truedsson L, Rönnblom L, Nordmark G, Sturfelt G, Blom AM. Mutations in genes encoding complement inhibitors CD46 and CFH affect the age at nephritis onset in patients with systemic lupus erythematosus. Arthritis Res Ther. 2011;13(6):R206. Epub 2011 Dec 15.
95.    Barbosa WS, Rodarte CM, Guerra JG, Maciel VG, Fleury Júnior LF, Costa MB. Bullous systemic lupus erythematosus. differential diagnosis with dermatitis herpetiformis. An Bras Dermatol. 2011 Jul-Aug;86(4 Suppl 1):S92-5. English, Portuguese.
96.    Perry D, Peck AB, Carcamo WC, Morel L, Nguyen CQ. The current concept of T (h) 17 cells and their expanding role in systemic lupus erythematosus. Arthritis. 2011;2011:810649. Epub 2011 Mar 22.
97.    Catalá-Rabasa A, Ndagire D, Sabio JM, Fedetz M, Matesanz F, Alcina A. High ACSL5 transcript levels associate with systemic lupus erythematosus and apoptosis in Jurkat T lymphocytes and peripheral blood cells. PLoS One. 2011;6(12):e28591.  Epub 2011 Dec 6.
98.    Karageorgas TP, Tseronis DD, Mavragani CP. Activation of type I interferon pathway in systemic lupus erythematosus. association with distinct clinical phenotypes. J Biomed Biotechnol. 2011;2011:273907. Epub 2011 Nov 16. Review.
99.    Salah S, Lotfy HM, Mokbel AN, Kaddah AM, Fahmy N. Damage index in childhood-onset systemic lupus erythematosus in Egypt. Pediatr Rheumatol Online J. 2011 Dec 9;9(1):36.
100.    Kim J, Kim N. Intestinal pseudo-obstruction. initial manifestation of systemic lupus erythematosus. J Neurogastroenterol Motil. 2011 Oct;17(4):423-4. Epub 2011 Oct 31.
101.    Suh-Lailam BB, Chiaro TR, Davis K W, Wilson AR, Tebo AE. Evaluation of a high avidity anti-dsDNA IgG enzyme-linked immunosorbent assay for the diagnosis of systemic lupus erythematosus. Int J Clin Exp Pathol. 2011;4(8):748-54. Epub 2011 Oct 30.
102.    Trivedi T, Franek BS, Green SL, Kariuki SN, Kumabe M, Mikolaitis RA, Jolly M, Utset TO, Niewold TB. Osteopontin alleles are associated with clinical characteristics in systemic lupus erythematosus. J Biomed Biotechnol. 2011;2011:802581. Epub 2011 Oct 26.
103.    He CS, Shi W, Ye ZM, Liang XL, Zhang B, Liu SX. [Cardiovascular risk profile in systemic lupus erythematosus. a cross-sectional study of 879 patients]. Nan Fang Yi Ke Da Xue Xue Bao. 2011 Nov;31(11):1910-3. Chinese.
104.    Rosa VE, Martin D, Lyrio AM, Teixeira MA, Provenza JR. Association of tibial osteomyelitis and pneumonitis due to miliary tuberculosis in a patient with systemic lupus erythematosus. Rev Bras Reumatol. 2011 Dec;51(6):645-7. English, Portuguese.
105.    Fraga MM, Len CA, dos Santos Finamor LP, Matos KT, Muccioli C, Hilário MO, Terreri MT. Ocular changes due to the treatment of juvenile systemic lupus erythematosus. Rev Bras Reumatol. 2011 Dec;51(6):554-7. English, Portuguese.
106.    Reynolds JA, Haque S, Berry JL, Pemberton P, Teh LS, Ho P, Gorodkin R, Bruce IN. 25-Hydroxyvitamin D deficiency is associated with increased aortic stiffness  in patients with systemic lupus erythematosus. Rheumatology (Oxford). 2012 Mar;51(3):544-51. Epub 2011 Nov 24.
107.    Fernández Rodríguez AM, Macías Fernández I, Navas García N. Systemic lupus erythematosus and Crohn's disease. a case report. Reumatol Clin. 2012 May-Jun;8(3):141-2. Epub 2011 Nov 25.
108.    Croca SC, Rahman A. Imaging assessment of cardiovascular disease in systemic lupus erythematosus. Clin Dev Immunol. 2012;2012:694143. Epub 2011 Oct 23. Review.
109.    Alaaeddine N, Hassan GS, Yacoub D, Mourad W. CD154. an immunoinflammatory mediator in systemic lupus erythematosus and rheumatoid arthritis. Clin Dev Immunol. 2012;2012:490148. Epub 2011 Oct 24. Review.
110.    Berzigotti A, Frigato M, Manfredini E, Pierpaoli L, Mulè R, Tiani C, Zappoli P, Magalotti D, Malavolta N, Zoli M. Liver hemangioma and vascular liver diseases in patients with systemic lupus erythematosus. World J Gastroenterol. 2011 Oct 28;17(40):4503-8.
111.    Klonowska-Szymczyk A, Robak E. [Current views on etiopathogenesis of systemic lupus erythematosus]. Postepy Hig Med Dosw (Online). 2011 Nov 8;65:683-703. Review. Polish.
112.    Lian LH, Kee BP, Ng HL, Chua KH. Lack of association between RANTES-28, SDF-1 gene polymorphisms and systemic lupus erythematosus in the Malaysian population. Genet Mol Res. 2011 Nov 17;10(4):2841-50.
113.    Płazak W, Gryga K, Sznajd J, Pasowicz M, Musiał J, Podolec P. Myocardial ischaemia in systemic lupus erythematosus. detection and clinical relevance. Kardiol Pol. 2011;69(11):1129-36.
114.    Zhong H, Li XL, Li M, Hao LX, Chen RW, Xiang K, Qi XB, Ma RZ, Su B. Replicated associations of TNFAIP3, TNIP1 and ETS1 with systemic lupus erythematosus in a southwestern Chinese population. Arthritis Res Ther. 2011;13(6):R186. Epub 2011 Nov 16.
115.    Kamel SR, Omar GM, Darwish AF, Asklany HT, Ellabban AS. Asymptomatic pulmonary hypertension in systemic lupus erythematosus. Clin Med Insights Arthritis Musculoskelet Disord. 2011;4:77-86. Epub 2011 Sep 28.
116.    Nakamura N, Sugawara T, Shirato K, Kumasaka R, Nakamura M, Shimada M, Fujita T, Murakami R, Shimaya Y, Osawa H, Yamabe H, Okumura K. Paroxysmal nocturnal hemoglobinuria in systemic lupus erythematosus. a case report. J Med Case Rep. 2011 Nov 14;5(1):550.
117.    Farid TM, Abd El Baky AM, Khalefa ES, Talaat AA, Mohamed AA, Gheita TA, Abdel-Salam RF. Association of tumor necrosis factor-alpha gene polymorphisms with juvenile systemic lupus erythematosus nephritis in a cohort of egyptian patients. Iran J Kidney Dis. 2011 Nov;5(6):392-7.
118.    Fiehn C. The first biological approved to treat systemic lupus erythematosus. Immunotherapy. 2011 Nov;3(11):1293-4.
119.    Kimkong I, Nakkuntod J, Sae-Ngow S, Snabboon T, Avihingsanon Y, Hirankarn N. Association between CTLA-4 polymorphisms and the susceptibility to systemic lupus erythematosus and Graves' disease in Thai population. Asian Pac J Allergy Immunol. 2011 Sep;29(3):229-35.
120.    Lizaso D, García M, Aguirre A, Esposto A. [Breast implant infection by Mycobacterium fortuitum in a patient with systemic lupus erythematosus]. Rev Chilena Infectol. 2011 Oct;28(5):474-8. Epub 2011 Oct 19. Spanish.
121.    Cunninghame Graham DS, Morris DL, Bhangale TR, Criswell LA, Syvänen AC, Rönnblom L, Behrens TW, Graham RR, Vyse TJ. Association of NCF2, IKZF1, IRF8, IFIH1, and TYK2 with systemic lupus erythematosus. PLoS Genet. 2011 Oct;7(10):e1002341. Epub 2011 Oct 27.
122.    Hughes T, Sawalha AH. The role of epigenetic variation in the pathogenesis of systemic lupus erythematosus. Arthritis Res Ther. 2011;13(5):245. Epub 2011 Oct 31.
123.    Lorenzoni PJ, Scola RH, Kay CS, Novak FT, Cardoso EH, Scalcon MR, Rachid Filho A, Werneck LC. Isolated hypoglossal nerve palsy. an unusual rare presentation in systemic lupus erythematosus. Arq Neuropsiquiatr. 2011 Oct;69(5):843-4.
124.    Matsumoto Y, Wakabayashi H, Otsuka F, Inoue K, Takano M, Sada KE, Makino H.  Systemic lupus erythematosus complicated with acute myocardial infarction and ischemic colitis. Intern Med. 2011;50(21):2669-73. Epub 2011 Nov 1.
125.    Barnabe C, Faris PD, Quan H. Canadian pregnancy outcomes in rheumatoid arthritis and systemic lupus erythematosus. Int J Rheumatol. 2011;2011:345727. Epub 2011 Oct 19.
126.    Ohl K, Tenbrock K. Inflammatory cytokines in systemic lupus erythematosus. J Biomed Biotechnol. 2011;2011:432595. Epub 2011 Oct 16. Review.
127.    Carmona-Fernandes D, Santos MJ, Perpétuo IP, Fonseca JE, Canhão H. Soluble receptor activator of nuclear factor κB ligand/osteoprotegerin ratio is increased in systemic lupus erythematosus patients. Arthritis Res Ther. 2011;13(5):R175. Epub 2011 Oct 25.
128.    Dubey AK, Handu SS, Dubey S, Sharma P, Sharma KK, Ahmed QM. Belimumab. First targeted biological treatment for systemic lupus erythematosus. J Pharmacol Pharmacother. 2011 Oct;2(4):317-9.
129.    Shiozawa S. Cause of systemic lupus erythematosus. a novel self-organized criticality theory of autoimmunity. Expert Rev Clin Immunol. 2011 Nov;7(6):715-7. Review.
130.    Li KJ, Wu CH, Hsieh SC, Lu MC, Tsai CY, Yu CL. Deranged bioenergetics and defective redox capacity in T lymphocytes and neutrophils are related to cellular dysfunction and increased oxidative stress in patients with active systemic lupus erythematosus. Clin Dev Immunol. 2012;2012:548516. Epub 2011 Oct 11.
131.    Ranzani OT, Battaini LC, Moraes CE, Prada LF, Pinaffi JV, Giannini FP, Shinjo SK, Azevedo LC, Park M. Outcomes and organ dysfunctions of critically ill  patients with systemic lupus erythematosus and other systemic rheumatic diseases. Braz J Med Biol Res. 2011 Nov;44(11):1184-93. Epub 2011 Oct 13.
132.    Matsumura M, Ito K, Kawamura R, Fujii H, Inoue R, Yamada K, Yamagishi M, Kawano M. Pneumococcal vertebral osteomyelitis and psoas abscess in a patient with systemic lupus erythematosus disclosing positivity of pneumococcal urinary antigen assay. Intern Med. 2011;50(20):2357-60. Epub 2011 Oct 15.
133.    Pathak S, Mohan C. Cellular and molecular pathogenesis of systemic lupus erythematosus. lessons from animal models. Arthritis Res Ther. 2011;13(5):241. Epub 2011 Sep 30.
134.    Onofiok E, Sivamani RK, Barr KL. Unilateral calciphylaxis in a patient with  systemic lupus erythematosus, chronic kidney disease, and hemodialysis-associated steal syndrome. Dermatol Online J. 2011 Sep 15;17(9):3.
135.    Koarada S, Tada Y, Suematsu R, Soejima S, Inoue H, Ohta A, Nagasawa K. Phenotyping of P105-negative B cell subsets in patients with systemic lupus erythematosus. Clin Dev Immunol. 2012;2012:198206. Epub 2011 Sep 26.
136.    Barreiro Delgado Y, García Méndez I, Martín Alemany N, Calabia Martínez J, Morales Fornos M, Fuertes M, Vallès Prats M. Libman-Sacks endocarditis and severe aortic regurgitation in a patient with systemic lupus erythematosus in peritoneal dialysis. Nefrologia. 2011;31(5):619-21. doi. 10.3265/Nefrologia.pre2011.Jun.10939. English, Spanish.
137.    Dolff S, Abdulahad WH, Westra J, Doornbos-van der Meer B, Limburg PC, Kallenberg CG, Bijl M. Increase in IL-21 producing T-cells in patients with systemic lupus erythematosus. Arthritis Res Ther. 2011;13(5):R157. Epub 2011 Sep  29.
138.    Nikpour M, Urowitz MB, Ibanez D, Harvey PJ, Gladman DD. Importance of cumulative exposure to elevated cholesterol and blood pressure in development of  atherosclerotic coronary artery disease in systemic lupus erythematosus. a prospective proof-of-concept cohort study. Arthritis Res Ther. 2011;13(5):R156. Epub 2011 Sep 29.
139.    Mackay M, Bussa MP, Aranow C, Uluğ AM, Volpe BT, Huerta PT, Argyelan M, Mandel A, Hirsch J, Diamond B, Eidelberg D. Differences in regional brain activation patterns assessed by functional magnetic resonance imaging in patients with systemic lupus erythematosus stratified by disease duration. Mol Med. 2011;17(11-12):1349-56. doi. 10.2119/molmed.2011.00185. Epub 2011 Sep 21.
140.    Marques Filho J. Phlegmasia cerulea dolens in patient with systemic lupus erythematosus in the remote postpartum period. Rev Bras Reumatol. 2011 Sep-Oct;51(5):514-6. English, Portuguese.
141.    Tiskievicz F, Mallmann ES, Brenol JC, Xavier RM, Spritzer PM. Prolactin, estradiol and anticardiolipin antibodies in premenopausal women with systemic lupus erythematosus. a pilot study. Rev Bras Reumatol. 2011 Sep-Oct;51(5):460-4.  English, Portuguese.
142.    Ghamarchehreh ME, Alishiri G, Bayat N, Khajehpoor H, Nooranipour M. Acute pancreatitis. an initial presentation of systemic lupus erythematosus. Turk J Gastroenterol. 2011 Aug;22(4):433-6.
143.    Cai YT, Peng XB. [Influence of serum prolactin on interleukin-6 secretion by peripheral blood mononuclear cells in patients with systemic lupus erythematosus]. Nan Fang Yi Ke Da Xue Xue Bao. 2011 Sep;31(9):1611-3. Chinese.
144.    Chai HC, Phipps ME, Chua KH. Genetic risk factors of systemic lupus erythematosus in the Malaysian population. a minireview. Clin Dev Immunol. 2012;2012:963730. Epub 2011 Sep 20. Review.
145.    Blasco Mata LM, Acha Salazar O, González-Fernández CR, Robledo FN, Pérez-Llantada Amunárriz E. Systemic lupus erythematosus and systemic autoimmune  connective tissue disorders behind recurrent diastolic heart failure. Clin Dev Immunol. 2012;2012:831434. Epub 2011 Sep 21.
146.    Koarada S, Tada Y. RP105-negative B cells in systemic lupus erythematosus. Clin Dev Immunol. 2012;2012:259186. Epub 2011 Sep 15. Review.
147.    Lazaros G, Aggelis A, Tsiachris D, Iliadis K, Scarpidi E, Bratsas A, Komnou  AA, Stefanadis C. Pericardial effusion in a young patient with newly diagnosed systemic lupus erythematosus and a mediastinal mass. Hellenic J Cardiol. 2011 Sep-Oct;52(5):448-51.
148.    Zhang B, Jiang DM, Zhou XC, Qi GX. Myocardial infarction in a patient with systemic lupus erythematosus and antiphospholipid syndrome. Chin Med J (Engl). 2011 Aug;124(15):2392-5.
149.    Jakuszko K, Krajewska M, Weyde W, Grzegorczyk K, Klinger M. [Pentraxins - their importance in pathogenesis of systemic lupus erythematosus]. Postepy Hig Med Dosw (Online). 2011 Sep 14;65:597-605. Review. Polish.
150.    Laurence BR, Suh B. Culture-negative bivalvular endocarditis with myocardial destruction in a patient with systemic lupus erythematosus. a case report. J Cardiothorac Surg. 2011 Sep 14;6:109.
151.    Taha Khalaf A, Song JQ, Gao TT, Yu XP, Lei TC. CTLA-4 gene polymorphism and  the risk of systemic lupus erythematosus in the Chinese population. J Biomed Biotechnol. 2011;2011:167395. Epub 2011 Sep 11.
152.    Pradhan V, Patwardhan M, Nadkarni A, Ghosh K. Fc γ R IIB gene polymorphisms  in Indian systemic lupus erythematosus (SLE) patients. Indian J Med Res. 2011 Aug;134:181-5.
153.    Anders HJ. Pigmented villonodular synovitis of the hip in systemic lupus erythematosus. a case report. J Med Case Rep. 2011 Sep 7;5:443.
154.    de Conti DO, Dias RR, Fiorelli AI, Stolf NA. Ruptured thoracic aortic aneurysm in patient with systemic lupus erythematosus. Rev Bras Cir Cardiovasc. 2011 Jan-Mar;26(1):128-30. English, Portuguese.
155.    Chen HH, Chen YM, Chen TJ, Lan JL, Lin CH, Chen DY. Risk of herpes zoster in patients with systemic lupus erythematosus. a three-year follow-up study using a  nationwide population-based cohort. Clinics (Sao Paulo). 2011;66(7):1177-82.
156.    Tuinman PR, Nieuwenhuis MB, Groen E, Kersten MJ. A young woman with generalised lymphadenopathy. Systemic lupus erythematosus (SLE). Neth J Med. 2011 Jun;69(6):284-8.
157.    García Pérez R, Ruiz de Angulo D, López Poveda MJ, Febrero Sánchez B, Navas  Carrillo D, Parrilla Paricio P. Hemorrhagic cholecystitis and hemobilia. two infrequent complications of systemic lupus erythematosus. Rev Esp Enferm Dig. 2011 Aug;103(8):431-3. English, Spanish.
158.    Guggino G, Giardina AR, Ciccia F, Triolo G, Dieli F, Sireci G. Are Toll-like receptors and decoy receptors involved in the immunopathogenesis of systemic lupus erythematosus and lupus-like syndromes? Clin Dev Immunol. 2012;2012:135932. Epub 2011 Aug 16. Review.
159.    Hughes GR, Cohen SA, Christian C. Anti-DNA activity in systemic lupus erythematosus. Isr Med Assoc J. 2011 May;13(5):273.
160.    Record JL, Beukelman T, Cron RQ. High prevalence of myositis in a southeastern United States pediatric systemic lupus erythematosus cohort. Pediatr Rheumatol Online J. 2011 Aug 9;9:20.
161.    Kim DP, Klein PA. Acquired cutis laxa in a 55-year-old female with multiple  myeloma and serologic evidence of systemic lupus erythematosus. Dermatol Online J. 2011 Jul 15;17(7):8.
162.    Garciá-Carrasco M, Mendoza-Pinto C, Riebeling C, Sandoval-Cruz M, Nava A, Etchegaray-Morales I, Jiménez-Hernández M, Montiel-Jarquín A, López-Colombo A, Cervera R. Influence of prevalent vertebral fractures on the quality of life of patients with systemic lupus erythematosus. Isr Med Assoc J. 2011 Jun;13(6):333-7.
163.    Hua-Li Z, Shi-Chao X, De-Shen T, Dong L, Hua-Feng L. Seasonal distribution of active systemic lupus erythematosus and its correlation with meteorological factors. Clinics (Sao Paulo). 2011;66(6):1009-13.
164.    Huang X, Guo Y, Bao C, Shen N. Multidimensional single cell based STAT phosphorylation profiling identifies a novel biosignature for evaluation of systemic lupus erythematosus activity. PLoS One. 2011;6(7):e21671. Epub 2011 Jul  22.
165.    Sacnun MP, Ferrer J, Ferrer M, Pons-Estel BA. [Rapidly progressive fatal interstitial lung disease in a patient with an overlap syndrome of systemic lupus erythematosus and systemic sclerosis]. Reumatol Clin. 2011 Jan-Feb;7(1):61-7. Epub 2010 Jun 19. Spanish.
166.    Pablos Álvarez JL. [Pathogenic basis of B cell targeted therapy in systemic  lupus erythematosus (SLE)]. Reumatol Clin. 2010 Sep;6S2:21-4. Epub 2010 Aug 4. Spanish.
167.    Calvo-Alén J, Mata C, Aurrecoechea E. [Utilization of hyperestrogenic therapies in systemic lupus erythematosus]. Reumatol Clin. 2010 Sep-Oct;6(5):264-7. Epub 2010 Jun 2. Spanish.
168.    González León R, Garrido Rasco R, Chinchilla Palomares E, García Hernández FJ, Castillo Palma MJ, Sánchez Román J. [Tuberculosis in a cohort of patients with systemic lupus erythematosus]. Reumatol Clin. 2010 Sep-Oct;6(5):256-61. Epub 2010 Sep 16. Spanish.
169.    Escudero González CM, Rodríguez Montero S, Martínez Pérez R, Pastor Mañosa C, Velloso Feijoo ML, Marenco de la Fuente JL. [Resistant orbital pseudotumor treated with rituximab in a patient with systemic lupus erythematosus. A case presentation]. Reumatol Clin. 2010 Jul-Aug;6(4):214-6. Epub 2010 Apr 10. Spanish.
170.    Shiari R, Farivar S. Juvenile Systemic Lupus Erythematosus associated with Klinefelter's syndrome. A case report. Reumatol Clin. 2010 Jul-Aug;6(4):212-3. Epub 2010 May 13.
171.    Rossoni C, Bisi MC, Keiserman MW, Staub HL. Antimalarials and cholesterol profile of patients with systemic lupus erythematosus. Rev Bras Reumatol. 2011 Jul-Aug;51(4):383-4, 386-7. English, Portuguese.
172.    Park KT, Hong KS, Han SJ, Yoon DH, Choi H, Lee MY, Ryu MS, Lee CW. Myopericarditis in a korean young male with systemic lupus erythematosus. Korean  Circ J. 2011 Jun;41(6):334-7. Epub 2011 Jun 30.
173.    Yamada R, Nozawa K, Yoshimine T, Takasaki Y, Ogawa H, Takamori K, Sekigawa I. A Case of Thrombotic Thrombocytopenia Purpura Associated with Systemic Lupus Erythematosus. Diagnostic Utility of ADAMTS-13 Activity. Autoimmune Dis. 2011;2011:483642. Epub 2011 Jul 11.
174.    Jesus AA, Jacob CM, Silva CA, Dorna M, Pastorino AC, Carneiro-Sampaio M. Common variable immunodeficiency associated with hepatosplenic T-cell lymphoma mimicking juvenile systemic lupus erythematosus. Clin Dev Immunol. 2011;2011:428703. Epub 2011 Jun 8.
175.    Plazak W, Gryga K, Dziedzic H, Tomkiewicz-Pajak L, Konieczynska M, Podolec P, Musial J. Influence of atorvastatin on coronary calcifications and myocardial  perfusion defects in systemic lupus erythematosus patients. a prospective, randomized, double-masked, placebo-controlled study. Arthritis Res Ther. 2011 Jul 20;13(4):R117.
176.    Bonin CC, Silva BS, Carvalho JF. Pandemic influenza A/H1N1 virus in a patient with systemic lupus erythematosus. Rev Inst Med Trop Sao Paulo. 2011 May-Jun;53(3):177.
177.    Crispín JC, Apostolidis SA, Finnell MI, Tsokos GC. Induction of PP2A Bβ, a regulator of IL-2 deprivation-induced T-cell apoptosis, is deficient in systemic  lupus erythematosus. Proc Natl Acad Sci U S A. 2011 Jul 26;108(30):12443-8. Epub  2011 Jul 11.
178.    Jacob N, Stohl W. Cytokine disturbances in systemic lupus erythematosus. Arthritis Res Ther. 2011 Jul 6;13(4):228. Review.
179.    Plazak W, Pasowicz M, Kostkiewicz M, Podolec J, Tomkiewicz-Pajak L, Musial J, Podolec P. Influence of chronic inflammation and autoimmunity on coronary calcifications and myocardial perfusion defects in systemic lupus erythematosus patients. Inflamm Res. 2011 Oct;60(10):973-80. Epub 2011 Jul 10.
180.    Luo X, Yang W, Ye DQ, Cui H, Zhang Y, Hirankarn N, Qian X, Tang Y, Lau YL, de Vries N, Tak PP, Tsao BP, Shen N. A functional variant in microRNA-146a promoter modulates its expression and confers disease risk for systemic lupus erythematosus. PLoS Genet. 2011 Jun;7(6):e1002128. Epub 2011 Jun 30.
181.    Mekouar F, Hammi S, Elomri N, Ghafir D. Bullous systemic lupus erythematosus. Intern Med. 2011;50(13):1445. Epub 2011 Jul 1.
182.    Kudaravalli J. Improvement in endothelial dysfunction in patients with systemic lupus erythematosus with N-acetylcysteine and atorvastatin. Indian J Pharmacol. 2011 May;43(3):311-5.
183.    Sobel ES, Brusko TM, Butfiloski EJ, Hou W, Li S, Cuda CM, Abid AN, Reeves WH, Morel L. Defective response of CD4(+) T cells to retinoic acid and TGFβ in systemic lupus erythematosus. Arthritis Res Ther. 2011 Jun 27;13(3):R106.
184.    Asadi Gharabaghi M, Abdollahi P, Kalany M, Sotoudeh M. Systemic lupus erythematosus presenting with eosinophilic enteritis. a case report. J Med Case Rep. 2011 Jun 25;5:235.
185.    Yuen HK, Holthaus K, Kamen DL, Sword DO, Breland HL. Using Wii Fit to reduce fatigue among African American women with systemic lupus erythematosus. a pilot study. Lupus. 2011 Oct;20(12):1293-9. Epub 2011 Jun 23.
186.    Wu Q, Yang Q, Lourenco E, Sun H, Zhang Y. Interferon-lambda1 induces peripheral blood mononuclear cell-derived chemokines secretion in patients with systemic lupus erythematosus. its correlation with disease activity. Arthritis Res Ther. 2011 Jun 16;13(3):R88.
187.    Shehata GA, Elserogy YM, Ahmad HE, Abdel-Kareem MI, Al-Kabeer AM, Rayan MM,  El-Baky ME. Multimodal neurophysiological and psychometric evaluation among patients with systemic lupus erythematosus. Int J Gen Med. 2011;4:325-32. Epub 2011 Apr 20. Erratum in. Int J Gen Med. 2011;4:547.
188.    McMahon M, Skaggs BJ, Sahakian L, Grossman J, FitzGerald J, Ragavendra N, Charles-Schoeman C, Chernishof M, Gorn A, Witztum JL, Wong WK, Weisman M, Wallace DJ, La Cava A, Hahn BH. High plasma leptin levels confer increased risk of atherosclerosis in women with systemic lupus erythematosus, and are associated with inflammatory oxidised lipids. Ann Rheum Dis. 2011 Sep;70(9):1619-24. Epub 2011 Jun 13.
189.    Baba S, Katsumata Y, Kawaguchi Y, Gono T, Sugiura T, Kanno T, Hara M, Yamanaka H. Association between low-dose pulsed intravenous cyclophosphamide therapy and amenorrhea in patients with systemic lupus erythematosus. a case-control study. BMC Womens Health. 2011 Jun 10;11:28.
190.    Verweij CL, Vosslamber S. Combining DNA-microarray data in systemic lupus erythematosus. Genome Med. 2011 May 31;3(5):30.
191.    Zhao J, Wu H, Khosravi M, Cui H, Qian X, Kelly JA, Kaufman KM, Langefeld CD, Williams AH, Comeau ME, Ziegler JT, Marion MC, Adler A, Glenn SB, Alarcón-Riquelme ME; BIOLUPUS Network; GENLES Network, Pons-Estel BA, Harley JB,  Bae SC, Bang SY, Cho SK, Jacob CO, Vyse TJ, Niewold TB, Gaffney PM, Moser KL, Kimberly RP, Edberg JC, Brown EE, Alarcon GS, Petri MA, Ramsey-Goldman R, Vilá LM, Reveille JD, James JA, Gilkeson GS, Kamen DL, Freedman BI, Anaya JM, Merrill  JT, Criswell LA, Scofield RH, Stevens AM, Guthridge JM, Chang DM, Song YW, Park JA, Lee EY, Boackle SA, Grossman JM, Hahn BH, Goodship TH, Cantor RM, Yu CY, Shen N, Tsao BP. Association of genetic variants in complement factor H and factor H-related genes with systemic lupus erythematosus susceptibility. PLoS Genet. 2011 May;7(5):e1002079. Epub 2011 May 26.
192.    Lech M, Römmele C, Kulkarni OP, Susanti HE, Migliorini A, Garlanda C, Mantovani A, Anders HJ. Lack of the long pentraxin PTX3 promotes autoimmune lung  disease but not glomerulonephritis in murine systemic lupus erythematosus. PLoS One. 2011;6(5):e20118. Epub 2011 May 27.
193.    Perez CA, Abdo N, Shrestha A, Santos ES. Systemic lupus erythematosus presenting as thrombotic thrombocytopenia purpura. how close is close enough? Case Report Med. 2011;2011:267508. Epub 2011 May 10.
194.    Alonso-Perez E, Suarez-Gestal M, Calaza M, Kwan T, Majewski J, Gomez-Reino JJ, Gonzalez A. Cis-regulation of IRF5 expression is unable to fully account for  systemic lupus erythematosus association. analysis of multiple experiments with lymphoblastoid cell lines. Arthritis Res Ther. 2011 May 31;13(3):R80.
195.    Studart SA, Rodrigues CL, Soares CB, Callado MR, Vieira WP. Systemic Lupus Erythematosus with muscle weakness due to Myasthenia Gravis. Rev Bras Reumatol. 2011 May-Jun;51(3):289-94. English, Portuguese.
196.    Nakashima CA, Galhardo AP, Silva JF, Fiorenzano GR, Santos AB, Leite MF, Nogueira MA, Menolli PV, Menolli RA. Incidence and clinical-laboratory aspects of systemic lupus erythematosus in a Southern brazilian city. Rev Bras Reumatol. 2011 May-Jun;51(3):231-9. English, Portuguese.
197.    Arasappan D, Tong W, Mummaneni P, Fang H, Amur S. Meta-analysis of microarray data using a pathway-based approach identifies a 37-gene expression signature for systemic lupus erythematosus in human peripheral blood mononuclear  cells. BMC Med. 2011 May 30;9:65.
198.    Bronson PG, Goldstein BA, Ramsay PP, Beckman KB, Noble JA, Lane JA, Seldin MF, Kelly JA, Harley JB, Moser KL, Gaffney PM, Behrens TW, Criswell LA, Barcellos LF. The rs4774 CIITA missense variant is associated with risk of systemic lupus erythematosus. Genes Immun. 2011 Dec;12(8):667-71. doi. 10.1038/gene.2011.36. Epub 2011 May 26.
199.    Villanueva E, Yalavarthi S, Berthier CC, Hodgin JB, Khandpur R, Lin AM, Rubin CJ, Zhao W, Olsen SH, Klinker M, Shealy D, Denny MF, Plumas J, Chaperot L,  Kretzler M, Bruce AT, Kaplan MJ. Netting neutrophils induce endothelial damage, infiltrate tissues, and expose immunostimulatory molecules in systemic lupus erythematosus. J Immunol. 2011 Jul 1;187(1):538-52. Epub 2011 May 25.
200.    Carrion FA, Figueroa FE. Mesenchymal stem cells for the treatment of systemic lupus erythematosus. is the cure for connective tissue diseases within connective tissue? Stem Cell Res Ther. 2011 May 11;2(3):23.

0 comments:

All links posted here are collected from various websites. No video or powerpoint files are uploaded on this blog. If you are the original author and do not wish to display your content on this blog please Email me anandkumarreddy at gmail dot com I will remove it. The contents of this blog are meant for educational purpose and not for commercial use. If you use any content give due credit to the original author.

This site uses cookies from Google to deliver its services, to personalise ads and to analyse traffic. Information about your use of this site is shared with Google. By using this site, you agree to its use of cookies.

  © Blogger templates Newspaper III by Ourblogtemplates.com 2008

Back to TOP